Heart valve repair or replacement surgeries are performed for damaged or diseased valves that may cause heart valve dysfunction (valve stenosis) and valve regurgitation (leaky valve). Heart valve repair is a surgical technique used to fix defects in heart valves in valvular heart diseases, and provides an alternative to valve replacement. The general techniques include either aortic valvuloplasty or mitral valvuloplasty, and valvulotomy. Heart valve replacement surgery invloves replacement of one or more of the heart valves with either an artificial heart valve or a bioprosthesis (homograft from human tissue or xenograft). The four replacement procedures include aortic valve replacement, mitral valve replacement, tricuspid valve replacement, and pulmonary valve replacement. Percutaneous aortic valve replacement (PAVR), or transcatheter aortic valve implantation (TAVI) or transcatheter aortic valve replacement (TAVR) involves replacement of the aortic valve of the heart through the blood vessels. The most common valve surgical procedure is aortic valve replacement for aortic stenosis, or narrowing of the aortic valve. More recently, transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve regurgitation therapy (TMVrep) has become a reality. In the recent years, transcatheter heart-valve management procedures with TAVR and TMVrep systems are gaining significant boost in terms of number of procedures performed worldwide due to new device approvals, technological advancements, and rising geriatric population.
The global heart valve repair and replacement devices market segmentation is based on device type – percutaneous balloon valvuloplasty (PBV), heart valve surgery, transcatheter devices – transcatheter aortic valve replacement (TAVR), and transcatheter mitral valve regurgitation therapy (TMVrep).
The global heart valve repair and replacement devices market research report provides market size (Revenue US$ Million 2014 to 2021), market share analysis, growth trends and forecast (CAGR%, 2017 to 2021). The global heart valve repair and replacement devices market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. In addition, the global heart valve repair and replacement devices market report provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis, and market profitability analysis by key products and regions or countries. The report also tracks the major competitors operating in the global market by company overview, financial snapshot, major products, technologies, services offered and recent developments.
Major players operating in the global heart valve repair and replacement devices market and profiled in this report include Abbott Laboratories, B. Braun Melsungen, Boston Scientific Corporation, Braile Biomedica, C.R. Bard, CarboMedics/LivaNova, Cardiac Dimension, CardiaMed, Cardiosolutions, Cook Medical, CryoLife, Edwards Lifesciences, FOC Medical, InterValve, JenaValve Technology, Labcor, Lanzhou Lanfei Medical Instrument, Lepu Medical, Medtronic, NeoChord, ON-X Life Technologies, Osypka Medical, Siemens Healthcare, Symetis, Toray Medical, TTK Healthcare, Valtech Cardio, and Vascutek/Terumo Corporation.